BB BIOTECH AG 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:20 pm Sale |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB BIOTECH AG | 300,000 4.400% |
-191,815 (-39.00%) |
Filing |
| 2022-02-11 4:41 pm Purchase |
2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB BIOTECH AG | 491,815 9.200% |
38,500 (+8.49%) |
Filing |
| 2021-02-12 4:52 pm Purchase |
2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB BIOTECH AG | 453,315 9.800% |
298,248 (+192.33%) |
Filing |